Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Recruiting · NCT04510636 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, classic Hodgkin lymphoma, neoplasm, refractory malignant neoplasm | Recruiting | Phase 2 | 2026-06-23 | NCT04510636 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Health Network, Toronto | 417 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Princess Margaret Cancer Centre | Toronto | Canada | 145 |